204 A phase II trial of a soy beverage for subjects without clinical disease with rising psa after radical radiation for prostate cancer

Radiotherapy and Oncology ◽

10.1016/s0167-8140(06)80945-x ◽

2006 ◽

Vol 80 ◽

pp. S59-S60

Author(s):

W. Kwan ◽

G. Duncan ◽

C. Van Patten ◽

M. Liu ◽

J. Lima

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Clinical Disease ◽

Radical Radiation

Download Full-text

A Phase II Trial of a Soy Beverage for Subjects Without Clinical Disease With Rising Prostate-Specific Antigen After Radical Radiation for Prostate Cancer

Nutrition and Cancer ◽

10.1080/01635580903305318 ◽

2010 ◽

Vol 62 (2) ◽

pp. 198-207 ◽

Cited By ~ 25

Author(s):

Winkle Kwan ◽

Graeme Duncan ◽

Cheri Van Patten ◽

Mitchell Liu ◽

Jan Lim

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Phase Ii ◽

Phase Ii Trial ◽

Specific Antigen ◽

Clinical Disease ◽

Radical Radiation

Download Full-text

Re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.02.031

European Urology ◽

10.1016/j.eururo.2021.06.003 ◽

2021 ◽

Author(s):

Wei Liu ◽

Katherine Zukotynski ◽

Glenn Bauman

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Curative Intent ◽

Trial Testing ◽

Prospective Phase

Download Full-text

Phase II trial of 5-fluorouracil and alpha-2b interferon in patients with hormone-refractory metastatic prostate cancer

Urology ◽

10.1016/s0090-4295(94)80096-0 ◽

1994 ◽

Vol 44 (3) ◽

pp. 377-380 ◽

Cited By ~ 4

Author(s):

Robert Dreicer ◽

Paula Kforest ◽

Richard D. Williams

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Metastatic Prostate Cancer ◽

Phase Ii Trial ◽

Hormone Refractory

Download Full-text

OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer

European Urology ◽

10.1016/j.eururo.2021.06.010 ◽

2021 ◽

Author(s):

Stéphane Supiot ◽

Loig Vaugier ◽

David Pasquier ◽

Xavier Buthaud ◽

Nicolas Magné ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Salvage Radiotherapy ◽

High Dose ◽

Pelvic Node ◽

Multicenter Phase

Download Full-text

A phase II trial of weekly i.v. KW-2170 in advanced castrate-resistant prostate cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/j.1743-7563.2010.01328.x ◽

2010 ◽

Vol 6 (4) ◽

pp. 292-297 ◽

Cited By ~ 1

Author(s):

Paul L DE SOUZA ◽

Scott NORTH ◽

Graeme B BOLGER ◽

Harris SPIRIDONIDIS ◽

Robert LIM ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Castrate Resistant Prostate Cancer ◽

Castrate Resistant

Download Full-text

Re: Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

The Journal of Urology ◽

10.1016/j.juro.2018.05.047 ◽

2018 ◽

Vol 200 (2) ◽

pp. 245-246

Author(s):

Samir S. Taneja

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Cancer Recurrence ◽

Multicenter Phase ◽

Prostate Cancer Recurrence ◽

Oligometastatic Prostate Cancer

Download Full-text

Phase II trial of anti-idiotypic p53 peptides (Pentrys) plus granulocyte-macrophage colony-stimulating factor in patients with hormone-refractory prostate cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/j.1743-7563.2007.00101.x ◽

2007 ◽

Vol 3 (3) ◽

pp. 148-155

Author(s):

Ian D DAVIS ◽

Guy TONER ◽

Adam BROAD ◽

Louise M CAMPANO ◽

Mark ROSENTHAL

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Hormone Refractory Prostate Cancer ◽

Colony Stimulating Factor ◽

Macrophage Colony Stimulating Factor ◽

Hormone Refractory ◽

Macrophage Colony ◽

Stimulating Factor ◽

P53 Peptides

Download Full-text

Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer

Cancer ◽

10.1002/cncr.21989 ◽

2006 ◽

Vol 107 (2) ◽

pp. 389-395 ◽

Cited By ~ 60

Author(s):

Nicholas Bruchovsky ◽

Laurence Klotz ◽

Juanita Crook ◽

Shawn Malone ◽

Charles Ludgate ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Biochemical Recurrence ◽

Advanced Prostate Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Locally Advanced Prostate Cancer ◽

Intermittent Androgen Suppression ◽

Prospective Phase ◽

Androgen Suppression

Download Full-text

PD-0807 MRI-Guided focal boost to intraprostatic lesion using VMAT in prostate cancer. A Phase II Trial.

Radiotherapy and Oncology ◽

10.1016/s0167-8140(21)07086-9 ◽

2021 ◽

Vol 161 ◽

pp. S640

Author(s):

A. Zapatero ◽

M. Roch ◽

P. Castro Tejero ◽

D. Büchser ◽

C. Martin de Vidales ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Mri Guided

Download Full-text

Oral Fenretinide in Biochemically Recurrent Prostate Cancer: A California Cancer Consortium Phase II Trial

Clinical Genitourinary Cancer ◽

10.3816/cgc.2009.n.008 ◽

2009 ◽

Vol 7 (1) ◽

pp. 43-50 ◽

Cited By ~ 16

Author(s):

Eric Cheung ◽

Jacek Pinski ◽

Tanya Dorff ◽

Susan Groshen ◽

David I. Quinn ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Recurrent Prostate Cancer

Download Full-text